Related Experiment Video
Updated: Jun 13, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Filamin a mediates HGF/c-MET signaling in tumor cell migration
Alex-Xianghua Zhou1, Aslı Toylu, Rajesh K Nallapalli
1Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden.
Abstract:
Deregulated hepatocyte growth factor (HGF)/c-MET axis has been correlated with poor clinical outcome and drug resistance in many human cancers. Identification of novel regulatory mechanisms influencing HGF/c-MET signaling may therefore be necessary to develop more effective cancer therapies. In our study, we show that multiple human cancer tissues and cells express filamin A (FLNA), a large cytoskeletal actin-binding protein, and expression of c-MET is significantly reduced in human tumor cells deficient for FLNA. The FLNA-deficient tumor cells exhibited poor migrative and invasive ability in response to HGF. On the other hand, the anchorage-dependent and independent tumor cell proliferation was not altered by HGF. The FLNA-deficiency specifically attenuated the activation of the c-MET downstream signaling molecule AKT in response to HGF stimulation. Furthermore, FLNA enhanced c-MET promoter activity by its binding to SMAD2. The impact of FLNA deficiency on c-MET expression and HGF-mediated cell migration in human tumor cells was confirmed in primary mouse embryonic fibroblasts deficient for Flna. These data suggest that FLNA is one of the important regulators of c-MET signaling and HGF-induced tumor cell migration.
Insights
Filamin A (FLNA) regulates hepatocyte growth factor (HGF)/c-MET signaling. FLNA deficiency impairs tumor cell migration by reducing c-MET expression and downstream AKT activation, suggesting FLNA as a therapeutic target in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The hepatocyte growth factor (HGF)/c-MET pathway is crucial in cancer progression and drug resistance.
- Understanding novel regulators of HGF/c-MET signaling is vital for developing effective cancer therapies.
Purpose of the Study:
- To investigate the role of filamin A (FLNA) in regulating HGF/c-MET signaling in human cancers.
- To determine the impact of FLNA on tumor cell migration and invasion.
Main Methods:
- Expression analysis of FLNA and c-MET in human cancer tissues and cells.
- Assessing tumor cell migration, invasion, and proliferation in FLNA-deficient cells.
- Investigating downstream signaling pathways, including AKT activation.
- Analyzing c-MET promoter activity and SMAD2 binding.
- Validation in Flna-deficient mouse embryonic fibroblasts.
Main Results:
- FLNA is expressed in human cancer cells, and its deficiency reduces c-MET expression.
- FLNA-deficient cells show impaired HGF-induced migration and invasion but unaltered proliferation.
- FLNA deficiency attenuates HGF-stimulated AKT activation.
- FLNA enhances c-MET promoter activity via SMAD2 binding.
Conclusions:
- Filamin A (FLNA) is a key regulator of c-MET signaling and HGF-induced tumor cell migration.
- FLNA's role in modulating c-MET expression and downstream signaling highlights its potential as a therapeutic target in cancer treatment.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Intracellular Signaling Affects Focal Adhesions
Some...
Cell Migration
Cell Migration
Cancer Cell Migration through Invadopodia

